Vir Biotechnology, Inc.
VIR
$10.80
-$0.39-3.44%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 54.26% | 23.36% | 16.09% | 6.32% | -13.91% |
| Total Depreciation and Amortization | -0.49% | -9.95% | -19.77% | -27.76% | -35.18% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -24.33% | -54.94% | -60.54% | -52.51% | -50.32% |
| Change in Net Operating Assets | -1,620.81% | -386.08% | 73.06% | 63.05% | 101.02% |
| Cash from Operations | 55.73% | -7.46% | 12.23% | 2.81% | -1.43% |
| Capital Expenditure | 87.83% | 49.09% | 33.82% | 5.29% | -14.68% |
| Sale of Property, Plant, and Equipment | -102.62% | -100.90% | -92.50% | 207.31% | 205.48% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -112.71% | -66.93% | -37.42% | 41.72% | 439.78% |
| Cash from Investing | -113.15% | -67.31% | -37.85% | 43.59% | 480.39% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5,496.32% | 3,268.58% | -8.94% | -14.10% | -19.04% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 99.74% | -118.79% | -118.79% | 25.59% | 8.94% |
| Cash from Financing | 6,046.27% | 3,328.01% | -13.74% | -16.57% | -22.04% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -71.37% | -145.30% | -235.23% | 59.10% | 97.05% |